Key Takeaways
- Ryan’s Law, officially California’s Compassionate Access to Medical Cannabis Act, allows terminally ill patients to use medicinal cannabis in specific healthcare settings.
- Patients must have valid medical documentation and cannot smoke or vape cannabis in these facilities.
- Healthcare facilities need to create policies that support Ryan’s Law, but staff cannot administer cannabis, leaving that to patients or caregivers.
- Oregon has enacted its own version of Ryan’s Law, expanding access but exempting hospitals from certain requirements.
- The implementation of Ryan’s Law highlights the need for improved education, compliance tracking, and patient rights in accessing medical cannabis.
Ryan’s Law is a healthcare-access law with a human story at its center.
Ryan Bartell was a 41-year-old U.S. Coast Guard veteran diagnosed with stage 4 pancreatic cancer. During his final weeks, he entered palliative hospital care and received powerful opioid medication. According to the Ryan’s Law Foundation and Americans for Safe Access, the hospital would not permit him to use medical cannabis. His family eventually found another facility that would.
Ryan’s father, Jim Bartell, has said that the change allowed his son to spend his final days more alert and able to interact with family and friends. After Ryan died in 2018, Jim began pushing for legislation so other families would not have to search for a cooperative facility while a loved one was dying.
That distinction matters. Ryan’s Law does not declare that cannabis is a universal substitute for opioids, and responsible reporting should not make that promise. Pain, nausea, appetite loss, anxiety and other symptoms near the end of life are medically complex. Cannabis may help some patients, may be inappropriate for others, and can carry risks or interact with other drugs. The principle behind Ryan’s Law is that qualified patients should not automatically lose access to a medicine authorized under state law simply because they enter a hospital, hospice or other covered healthcare setting.
In plain English, the law is about preserving patient choice, continuity of care and human presence during some of life’s hardest hours.
What Is Ryan’s Law?
California enacted Senate Bill 311 in 2021. The measure added the Compassionate Access to Medical Cannabis Act, commonly known as Ryan’s Law, to the California Health and Safety Code. It became effective January 1, 2022.
The original act required specified healthcare facilities to permit medicinal cannabis use by terminally ill patients, subject to safety, documentation and storage rules. It defined “terminally ill” as a medical condition that would result in a life expectancy of one year or less if the disease followed its natural course.
California subsequently refined the law:
- SB 988 in 2022 addressed operational confusion surrounding how medicinal cannabis should be handled inside facilities. The later statutory framework makes the patient or primary caregiver responsible for acquiring, retrieving, administering and removing the cannabis and prohibits facility personnel from administering it or retrieving it from storage.
- SB 302 in 2023 expanded eligibility in certain settings to patients over 65 with a chronic disease when a physician has assessed a serious medical condition and determined medicinal cannabis is appropriate. It added licensed home health agencies, required covered facilities not to deny admission because of medicinal cannabis use, and refined the circumstances in which a facility may suspend compliance because of federal action or inquiry.
These amendments make one thing clear: Ryan’s Law is not frozen in its original 2021 form. Any guide that describes it only as a terminal-illness hospital bill is now incomplete.
Who Qualifies Under California’s Ryan’s Law?
California law recognizes two qualifying paths.
The first is a patient who is terminally ill, meaning the patient has a medical condition with a prognosis of one year or less if it follows its natural course.
The second, added through SB 302, is a patient over 65 with a chronic disease who has received a physician’s assessment that the patient has a serious medical condition and that medicinal cannabis use is appropriate.
There is an important limitation. A general acute care hospital is not required to permit medicinal cannabis use by a patient qualifying only through the over-65 chronic-disease provision. Terminally ill patients remain covered in those hospitals, but the expanded chronic-disease category is more limited by setting.
Qualified patients must also provide either a valid California Medical Marijuana Identification Card or qualifying written documentation, such as an appropriate physician recommendation under California law. Adult-use legality by itself is not enough. Ryan’s Law concerns medicinal cannabis and requires medical documentation.
Which Healthcare Settings Are Covered?
The California framework applies to specified licensed settings, including general acute care hospitals, special hospitals, skilled nursing facilities, congregate living health facilities, hospice facilities and licensed home health agencies.
It does not apply in the same way everywhere. Excluded settings include state hospitals and chemical dependency recovery hospitals. Emergency departments are excluded while a patient is receiving emergency services and care.
The practical lesson is simple: patients and caregivers should not assume that every room, department or healthcare organization follows identical rules. Before admission, ask the specific facility for its written Compassionate Access to Medical Cannabis Act policy and identify the person responsible for implementing it.
What Forms of Medical Cannabis Are Allowed?
Ryan’s Law does not authorize smoking or vaping inside covered facilities. For most facilities, those methods must be prohibited. Home health agencies must prohibit smoking or vaping immediately before or while their personnel are present in the residence.
Non-inhaled products may fit within facility policy when the patient is otherwise qualified. Depending on the patient’s medical plan and the facility’s rules, this can include products such as tinctures, capsules, tablets, oils or other non-smokable preparations.
That does not mean every product is automatically appropriate. Formulation, potency, onset time, duration, drug interactions and the patient’s ability to swallow or self-administer all matter. Patients should discuss cannabis use with the clinicians overseeing their care and should not change prescribed treatment without medical guidance.
What Patients and Caregivers Must Do
Under California’s current framework, the patient or primary caregiver carries most of the operational responsibility. They must:
- Provide valid medical-cannabis documentation.
- Acquire and bring the medicinal cannabis through lawful channels
- Retrieve it from secured storage
- Administer it without relying on facility staff.
- Keep it secured in a locked container in the patient’s room, another designated area or with the caregiver.
- Remove any remaining product when the patient is discharged.
If cannabis is left behind and neither the patient nor an available caregiver can remove it, the facility must keep it secured until disposal under its policy.
Patients should prepare before a planned admission. Bring copies of the recommendation or MMIC, retain product labels and purchase records, use a lockable container, list the products and doses being used, and identify a primary caregiver who can be present if the patient may become unable to self-administer.
Do not wait until a crisis to ask whether the facility has a policy. That is precisely when bureaucratic fog becomes most expensive.
What Healthcare Facilities Must Do
Covered facilities must do more than reluctantly look the other way. California law directs them to create a controlled process for qualifying medicinal cannabis use.
Depending on the facility type, required actions include:
- Permitting qualifying use under the statute.
- Recording medicinal cannabis use in the patient’s medical record.
- Verifying the patient’s MMIC or qualifying physician documentation.
- Requiring secure storage.
- Developing and distributing written guidelines.
- Training staff on the facility’s guidelines.
- Establishing procedures for cannabis left behind after discharge.
- Ensuring that admission is not denied in whole or in part because the patient uses medicinal cannabis.
Americans for Safe Access has published a healthcare-facility implementation guide with sample verification procedures, patient notices, policy language and operational steps. That resource matters because many failures attributed to legal uncertainty” are really failures to establish a workable chain of custody, documentation process and staff protocol.
The Biggest Gap: Staff Cannot Administer the Cannabis
Ryan’s Law opened the door, but it did not remove every barrier.
California prohibits healthcare professionals and facility personnel, including physicians, nurses and pharmacists, from administering medicinal cannabis or retrieving it from storage. The patient or primary caregiver must perform those actions.
For a mobile, alert patient with an available caregiver, that may be manageable. For someone with advanced ALS, late-stage cancer, severe neurological disease, dementia, swallowing problems or declining consciousness, it can make the legal right nearly impossible to use.
This is the implementation fault line advocates continue to emphasize. The patients most likely to need compassionate access may be the least able to physically exercise it. A family member cannot always remain at the bedside around the clock. Some patients do not have an available primary caregiver. Others deteriorate quickly after admission.
The result is a strange policy compromise: the facility must permit qualifying use, but the professionals already providing medication and hands-on care are barred from administering the cannabis. Until that contradiction is addressed, access will remain uneven.
What Early Implementation Tells Us
California does not yet have the kind of comprehensive public reporting needed to measure statewide compliance, patient use, adverse events or denials. The available evidence is promising but limited.
Beard Bros previously reported on an implementation experience in the solid-tumor oncology unit at UCLA Santa Monica Medical Center. Between May 2022 and June 2024, eight inpatients reportedly used medical cannabis under Ryan’s Law. The published report described no safety events in that small group. Nurses involved in the program generally reported comfort with the process and perceived symptom benefits, but the sample was tiny, involved one institution and focused on patients with terminal cancer.
That experience is useful because it shows that a hospital can build a policy and integrate patient-directed medicinal cannabis use without the sky falling. It is not proof that every hospital, patient or cannabis product will produce the same outcome.
A separate retrospective hospice study published in the American Journal of Hospice and Palliative Medicine examined medical marijuana as a complementary approach alongside scheduled opioids. Research of this kind can inform better care, but it does not erase the need for individualized clinical assessment, standardized products, interaction screening and larger controlled studies.
The honest conclusion is neither “cannabis solves end-of-life care” nor “there is no evidence.” The evidence base is developing, patient demand is real, and healthcare systems need policies capable of responding responsibly.
Why Facilities Still Hesitate
Healthcare organizations operate where state cannabis law, federal drug law, accreditation, Medicare and Medicaid participation, pharmacy rules, risk management and clinical ethics collide. That collision has made many institutions cautious.
California law anticipates some of that concern. A facility may suspend compliance if a federal agency, the U.S. Department of Justice or the Centers for Medicare & Medicaid Services takes specified enforcement action, issues an express prohibition or makes a qualifying inquiry into the facility’s activities. However, the statute does not allow a facility to prohibit use solely because cannabis is federally controlled or because of federal constraints that already existed when the law was enacted.
Federal cannabis policy has continued to change, but federal reform should not be confused with nationwide legalization or automatic approval of every state cannabis product as a prescription drug. Even when scheduling policy shifts, healthcare systems still face questions concerning product verification, dosing consistency, impairment, interactions, informed consent, storage and documentation.
Those are legitimate operational questions. They are not a license to pretend Ryan’s Law does not exist.
Oregon Has Now Enacted Its Own Ryan’s Law
Beard Bros reported in February 2026 that Oregon House Bill 4142 was advancing through the legislature. The story has since moved from proposal to law.
Oregon Governor Tina Kotek approved HB 4142 on April 7, 2026. The act became effective June 5, 2026, and its primary Ryan’s Law provisions become operative January 1, 2027. Covered organizations have later deadlines to complete written policies and make staff training available.
Oregon’s approach is not a carbon copy of California’s. It focuses on organizations providing hospice, palliative or home health services and certain residential facilities that are designated as additional caregivers under Oregon’s medical marijuana program. Hospitals and hospital-affiliated clinics are exempt from the central requirements.
Covered organizations and residential facilities must allow eligible registered patients or residents to engage in the medical use of marijuana on the premises. They must create policies addressing procurement, storage, administration and disposal. Direct-care personnel must receive education covering cannabis pharmacology, dosing strategies, delivery methods, contraindications and potential drug interactions before providing direct care to participating patients.
The Oregon law also expands the state’s definition of a debilitating medical condition to include the need for hospice, palliative care, comfort care or other symptom management, including comprehensive pain management. It protects qualifying organizations and personnel under specified state criminal laws and protects nurses from discipline merely for discussing medical marijuana with patients.
There is real progress here, but also a tradeoff. Oregon goes further than California in requiring relevant staff education and expressly addressing administration in facility policy. At the same time, its hospital exemption leaves a major category of institutional care outside the mandate.
Ryan’s Law Is Becoming a National Model, but State Laws Differ
California’s legislation has helped shape broader efforts to protect medical-cannabis access in healthcare settings. Maryland and North Dakota have adopted related provisions, and other states have considered bills addressing administration or use in hospitals, hospice programs, assisted living facilities and residential care.
These laws should not be treated as interchangeable. They differ on fundamental questions:
- Who qualifies?
- Are hospitals covered or exempt?
- Can personnel administer cannabis?
- Must the patient be registered in the state medical program?
- Which product forms are allowed?
- What documentation is required?
- Who controls storage and disposal?
- Is staff training required?
- What protections exist for employees and facilities?
Maryland’s 2024 legislation, for example, authorized designated medical personnel in specified care settings to administer medical cannabis under defined conditions and provided legal protections for those workers. That directly addresses a problem California still leaves largely with patients and caregivers.
The emerging national lesson is not that one statute can simply be pasted into every state code. The lesson is that compassionate access requires both a legal right and an operational system.
A Practical Ryan’s Law Checklist for Patients and Families
Before a planned admission to a California facility:
- Ask for the facility’s written Ryan’s Law or medicinal-cannabis policy.
- Confirm that the specific facility and unit are covered.
- Obtain a current physician recommendation or verify that the MMIC remains valid.
- Tell the treating team what cannabis products are being used and why.
- Ask about possible interactions, impairment and conflicts with the treatment plan.
- Bring cannabis only in a clearly labeled form obtained lawfully.
- Bring a lockable storage container if the facility requires one.
- Designate an eligible primary caregiver who can retrieve and administer the product.
- Decide who will remove remaining cannabis at discharge.
- Document the names, dates and explanations if access is denied.
If a disagreement arises, request the policy in writing and ask to speak with the charge nurse, attending physician, patient advocate, risk-management representative or facility administrator. A patient should not need to become a lawyer from a hospital bed, but documentation helps separate a genuine statutory exception from staff unfamiliarity or an unwritten blanket prohibition.
What Healthcare Leaders Should Do Now
Administrators do not need to invent a program from scratch. They should review the current statute and implementation resources, assign clear ownership and test the process before a patient request arrives.
A functional policy should answer:
- Who verifies the patient’s documentation?
- Who verifies the patient’s documentation?
- Which non-inhaled forms are permitted?
- Where and how is the cannabis locked?
- Who can access the storage location?
- How are adverse effects or suspected interactions reported?
- What happens if the patient loses the ability to self-administer?
- How is a primary caregiver identified and documented?
- How is unused product removed or destroyed?
- Who handles a complaint or denial?
Training should reach more than senior leadership. A policy nobody on the floor has seen is not implementation. Nurses, physicians, pharmacists, social workers, admission personnel, risk managers and patient advocates all need to understand their roles and their limits.
What Must Happen Next
Ryan’s Law has already changed the policy conversation. It established that entering a healthcare facility should not automatically erase a qualifying patient’s access to medicinal cannabis. It has inspired other states and forced healthcare administrators to confront an issue many preferred to avoid.
The next phase must focus on execution.
California needs better public information about facility policies, requests, approvals, denials and safety outcomes. Patients need a clear complaint pathway. Facilities need practical education instead of rumor-driven fear. Researchers need larger studies involving different diagnoses, products and care settings. Lawmakers need to confront the self-administration gap without abandoning patient safety.
Most of all, the movement must keep Ryan Bartell’s story at the center. This was never about giving cannabis special treatment. It was about refusing to give qualified patients worse treatment because their medicine remains politically inconvenient.
Compassion cannot stop at the hospital door. Neither should a patient’s dignity.
Frequently Asked Questions
Ryan’s Law is the common name for California’s Compassionate Access to Medical Cannabis Act. It requires specified healthcare facilities to permit qualifying medicinal cannabis use under rules governing documentation, storage, administration, medical records and disposal.
Yes, qualifying terminally ill patients may use medicinal cannabis in covered California hospitals, subject to the statute and facility policy. Emergency departments are excluded while patients receive emergency services. Patients qualifying only because they are over 65 with a chronic disease are not covered for use in general acute care hospitals.
Not under California’s current framework. Healthcare professionals and facility staff, including nurses, physicians and pharmacists, are prohibited from administering medicinal cannabis or retrieving it from storage. The patient or primary caregiver must perform those tasks.
No. Smoking and vaping medicinal cannabis are prohibited in covered California healthcare facilities. Home health agencies must prohibit smoking or vaping immediately before or while personnel are present in the residence.
A patient must provide a valid California Medical Marijuana Identification Card or qualifying written medical documentation. Adult-use eligibility alone does not activate Ryan’s Law protections.
California law requires covered facilities to ensure that a patient is not denied admission in whole or in part because of medicinal cannabis use. Other legitimate admission criteria and statutory exclusions may still apply.
Yes. California’s covered settings include hospice facilities, and Oregon’s enacted Ryan’s Law focuses heavily on hospice, palliative care and certain residential facilities. The details and eligibility requirements differ by state.
No. Ryan’s Law refers to state legislation. California enacted the original law, and other states have adopted or considered related measures. Federal law and federal healthcare requirements continue to affect how facilities assess risk and build policies.
Ask for the facility’s written policy and the specific reason for denial. Request review by the attending physician, charge nurse, patient advocate, risk-management office or administrator. Preserve written communications and document the names and dates involved. Patients and families may also seek help from a qualified California attorney or a medical-cannabis patient advocacy organization.
Oregon HB 4142 was approved April 7, 2026, and became effective June 5, 2026. Its main requirements become operative January 1, 2027, with later implementation deadlines for written policies and staff training.
